Madrigal Pharmaceuticals MDGL
NASDAQ MDGL
$499.40 -0.31 (-0.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Madrigal Pharmaceuticals (MDGL) Cash & Current Investments (2010 - 2026)

Updated

Madrigal Pharmaceuticals (MDGL) recorded Cash & Current Investments of $838.75 million in Q2 2026, up 5.2% from $797.02 million a year earlier and up 3.2% from the prior quarter.

Analysis

Madrigal Pharmaceuticals (MDGL) Cash & Current Investments (2010 - 2026) Analysis & Trends

At the end of FY2025, Madrigal Pharmaceuticals reported Cash & Current Investments of $983.56 million, up 6.2% from FY2024.

  • Annual Cash & Current Investments has increased for four straight years, with a five-year compound annual growth rate of 28.2% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $926.25 million in FY2024 (+46.1%), $634.13 million in FY2023 (+76.7%), $358.77 million in FY2022 (+32.7%) and $270.35 million in FY2021 (-4.9%).
  • Quarterly Cash & Current Investments has ranged from $153.19 million in Q3 2022 to $1.11 billion in Q3 2025 over the past five years.
  • On a year-over-year basis, Cash & Current Investments rose in five of the last eight quarters, with growth averaging 43.7%.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 329.8% in Q3 2024, against a decline of 48.8% in Q3 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $812.77 million (Q1 2026), $983.56 million (Q4 2025) and $1.11 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Madrigal Pharmaceuticals 14.56 Bn 10.81 Bn - 838.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 838.75 Mn
Mar 31, 2026 812.77 Mn
Dec 31, 2025 983.56 Mn
Sep 30, 2025 1.11 Bn
Jun 30, 2025 797.02 Mn
Mar 31, 2025 843.07 Mn
Dec 31, 2024 926.25 Mn
Sep 30, 2024 998.63 Mn
Jun 30, 2024 1.06 Bn
Mar 31, 2024 1.06 Bn
Dec 31, 2023 634.13 Mn
Sep 30, 2023 232.35 Mn
Jun 30, 2023 298.42 Mn
Mar 31, 2023 329.48 Mn
Dec 31, 2022 358.77 Mn
Sep 30, 2022 153.19 Mn
Jun 30, 2022 211.77 Mn
Mar 31, 2022 219.95 Mn
Dec 31, 2021 270.35 Mn
Sep 30, 2021 299.14 Mn
API Access

Madrigal Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=MDGL&period=max&api_key=YOUR_API_KEY